Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis

Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis

Introduction Plasmacytoid variant bladder cancer is a rare variant of urothelial carcinoma that accounts for 1% of bladder cancers. Plasmacytoid variant urothelial carcinoma is characterized by an aggressive phenotype and poor clinical outcomes. Case presentation A 61‐year‐old woman presented with g...

Full description

Bibliographic Details
Main Authors: Yusuke Goto, Satoki Tanaka, Masafumi Maruo, Sho Sugawara, Kazuto Chiba, Kanetaka Miyazaki, Atsushi Inoue, Tomohiko Ichikawa, Maki Nagata
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:IJU Case Reports
Subjects:
bladder cancer
high tumor mutation burden
pembrolizumab
plasmacytoid variant
Online Access:https://doi.org/10.1002/iju5.12463

Internet

https://doi.org/10.1002/iju5.12463

Similar Items